Rappel de Afinion AS100 Analyser, CRP and CRP Control; An in vitro diagnostic medical device (IVD)

Selon Department of Health, Therapeutic Goods Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à Australia qui a été fabriqué par Inverness Medical Innovations Australia Pty Ltd.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
  • ID de l'événement
  • Classe de risque de l'événement
    Class II
  • Date de mise en oeuvre de l'événement
  • Pays de l'événement
  • Source de l'événement
  • URL de la source de l'événement
  • Notes / Alertes
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notes supplémentaires dans les données
  • Cause
    1) axis-shield poc as, the manufacturer of afinion crp system, warns that an information code (error code) which is displayed on the analyser screen might potentially be misinterpreted as a high crp result. 2) the crp concentration in frequently opened control vials may increase due to evaporation. therefore, the stability of opened vials of afinion crp control has been reduced from 8 to 4 weeks.
  • Action
    Alere is providing work around instructions and will be implementing a software update.


  • Modèle / numéro de série
    Afinion AS100 Analyser, CRP and CRP Control; An in vitro diagnostic medical device (IVD)Afinion AS100 AnalyserREF: 1115027, 1115173, 1115174, 1115176, 1115172, 1115175, 1115507, 1115419 & 1115516Afinion CRPREF: 1115013, 1115014 & 1115377Afinion CRP ControlREF: 1114993
  • Manufacturer


  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source